Six research discoveries with the potential to provide benefit to society have been awarded funding from the University’s Intellectual Property Accelerator Fund, which aims to speed the development of innovative projects into real-world applications. One of the winning technologies this year aims to reduce the risk of heart disease and stroke through treatments that inhibit the enzyme Nocturnin (pictured).